Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit

Evidence from trials: Summary of a fantastic decade

Date

22 Oct 2023

Session

Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit

Topics

Tumour Site

Prostate Cancer

Presenters

Dana Rathkopf

Authors

D. Rathkopf

Author affiliations

  • Medicine Department, MSKCC - Memorial Sloan Kettering Cancer Center, 10065 - New York/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

How to best integrate biology

Presenter: Gerhardt Attard

Session: Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit

Resources:

Slides

Webcast

Tolerance and long-term side-effects

Presenter: Alicia Morgans

Session: Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Dissecting metastatic castration-sensitive prostate cancer (mCSPC) for optimal patient benefit

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.